Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors

被引：0
|
作者：
Amir Sabet
James Nagarajah
Ahmet Semih Dogan
Hans-Jürgen Biersack
Amin Sabet
Stefan Guhlke
Samer Ezziddin
机构：
[1] University Hospital,Department of Nuclear Medicine
[2] University Hospital,Department of Nuclear Medicine
来源：
EJNMMI Research | / 3卷
关键词：
Positron Emission Tomography; Tumor Lesion; Peptide Receptor Radionuclide Therapy; Normal Liver Parenchyma; Receptor Saturation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 2 条
  • [1] Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
    Sabet, Amir
    Nagarajah, James
    Dogan, Ahmet Semih
    Biersack, Hans-Juergen
    Sabet, Amin
    Guhlke, Stefan
    Ezziddin, Samer
    EJNMMI RESEARCH, 2013, 3 : 1 - 6
  • [2] Delayed Haematological Toxicity in Patients Treated with 177Lu-octreotate Peptide Receptor Radiotherapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs)
    Hentic, O.
    Lebtahi, R.
    Kwekkeboom, D. J.
    Fenaux, P.
    Palazzo, M.
    Boudabous, H.
    Benreguiga, M.
    Rebours, V.
    Maire, F.
    Hammel, P.
    Ruszniewski, P.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 282 - 283
1